Prof. Daniel HS Lee

Professor Daniel HS Lee

Associate Vice-President (Innovation and Enterprise)
Honorary professor, School of Biomedical Sciences

BSc (Hons), (HKU); PhD, Pathology (HKU)

Curriculum Vitae

Education & Employment


  • 1978, B. Sc (Hons), University of Hong Kong
  • 1988, Ph. D, Pathology, University of Hong Kong


  • 2019-present, Associate Vice President (Innovation & Enterprise), The Chinese University of Hong Kong
  • 2019-present, Honorary Professor, Chinese University of Hong Kong
  • 2013-present, Adjunct Professor, University of Hong Kong Science and Technology
  • 2013-2018, Biomedical Technology Cluster Head, Hong Kong Science & Technology Parks Corporation
  • 2010-present, Honorary Professor, Faculty of Medicine, University of Hong Kong
  • 2010-2013, General Manager and site Head, Roche Pharma Research and Early Development China, Shanghai
  • 2008-2010, Senior Director and Head, Translational Medicine, Senior Director, Neurodegeneration, Global co-Director, Rare Diseases, GlaxoSmithKline China, Shanghai
  • 2000-2008, Program Leader, Biogen Inc USA, Boston
  • 1991-2000, Senior Scientist, Johnson & Johnson USA, Philadelphia
  • 1989-1990, Visiting Scientist, Terry Fox Laboratory, BC Cancer Agency, Vancouver, Canada
  • 1983-1990, Staff Tutor, Clinical Biochemistry Unit, Queen Mary Hospital, University of Hong Kong

Research Interests

  • Alzheimer’s disease, advanced therapeutics, drug discovery and development, bioinformatics, translational medicine, Ph I/II clinical trial design


  • 1995, National Medal, Johnson & Johnson
  • 1989-1990, Canada MRC Fellowship
  • 1981, Monbusho Scholarship
  • 1978, Distinction in Biochemistry, HKU

Public Services

  • Active, Ad hoc Journal reviewer
  • 2020-present, Innovation and Technology Commission ITF Research Project Assessment Panel
  • 2019-present, Logistic and Supply Chain Multitech Board member,
  • 2019, Organizing Committee member, First Human Genome Editing Conference
  • 2018-present, International Human Epigenetics Ethics Committee member
  • 2018-present, Life Science Society Advisor
  • 2015-2019, Clinical Trials Center, Chinese University of Hong Kong, Advisor
  • 2013-present, School of Pharmacy, Chinese University of Hong Kong, Advisory Board member
  • 2001-present, Alzheimer’s Association USA Grant reviewer